Recruiting

Observational Study

Sponsor:

Inspire Medical Systems, Inc.

Code:

NCT07113288

Conditions

Obstructive Sleep Apnea (OSA)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Inspire® UAS System

Study Details

Brief summary:

The purpose of this observational clinical study is to provide evaluation of long-term safety and effectiveness in a newly expanded patient population including patients with a higher AHI and a higher BMI.

Conditions

Obstructive Sleep Apnea (OSA)

Study ID

NCT07113288

Start date

Jul 31, 2025

Status verified date

Aug, 2025

Completion date

Jan 1, 2032

Anticipated

Primary completion date

Jan 1, 2032

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Subject is at least 18 years of age;
2. Subject has a diagnosis of severe OSA (65 ≤ AHI ≤ 100) based on a recent sleep study (within 12 months) OR Subject has a diagnosis of moderate to severe OSA (15≤AHI≤100) AND a baseline Body Mass Index of 32<BMI≤40 kg/m2;
3. Subject has documented failure of, or intolerance to, positive airway pressure treatments (such as CPAP or BPAP machines; NOTE: PAP failure is defined as an inability to eliminate OSA (AHI > 15 despite PAP usage). PAP intolerance is defined as the inability to use PAP (> 5 nights per week, 4 hours of usage per night) or unwillingness to use PAP (e.g. patient returns the PAP system after attempting to use it).
4. Subject is willing and able to have stimulation hardware permanently implanted and to use the patient remote to activate the stimulation;
5. Subject is willing and able to return for follow-up visits, undergo sleep studies (including in-lab and at-home), and complete questionnaires related to the study;
6. Subject is willing and able to provide informed consent.

Exclusion Criteria:

1. Subject has a combination of central + mixed apneas > 25% of the total apnea-hypopnea index (AHI) based on a recent sleep study (within 12 months);
2. Subject has any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate;
3. Subject has any condition or procedure that has compromised neurological control of the upper airway;
4. Subject is unable or does not have the necessary assistance to operate the patient remote;
5. Subject is pregnant or plans to become pregnant;
6. Subject has an implantable device that may be susceptible to unintended interaction with the Inspire System;
7. Subject has a terminal illness with life expectancy < 12 months;
8. Any other reason the investigator deems the subject is unfit for participation in the study.

Study Design

Enrollment

70 participants

Anticipated

Interventions and Outcome Measures

Arms

High AHI

Following patients with 65<AHI≤100 events/hr after Inspire Implantation for a period of 5 years

High BMI

Following patients with 32<BMI≤40 kg/m2 after Inspire Implantation for a period of 5 years

Interventions

Inspire® UAS System

Participants will be implanted with a commercially available Inspire® UAS System. In addition, participants will receive a patient remote which is used to initiate therapy each night.

Primary outcome measure

  • Incidence of Procedure and/or Device Related Adverse Events (Safety and Tolerability) [ Time Frame: 5 years post-implant ]

Central Contacts and Locations

Central contacts

Locations

Colorado ENT & Allergy

Recruiting

Colorado Springs, Colorado, United States, 80923

Contacts

Principal Investigator:

Dr. Nicholas Beckmann, DO

Florida Sleep Specialists

Recruiting

Bradenton, Florida, United States, 34209

Contacts

Principal Investigator:

Jeremy McConnell, MD

Rush University Medical Center

Recruiting

Chicago, Illinois, United States, 60612

Contacts

Principal Investigator:

Michael Hutz, MD

University of Kansas Medical Center

Recruiting

Kansas City, Kansas, United States, 66160

Contacts

Bryan Humphrey

bhumphrey@kumc.edu

Principal Investigator:

Damien Stevens, MD

University of Rochester

Recruiting

Rochester, New York, United States, 14642

Contacts

Principal Investigator:

Sveta Karelsky, MD

More Information

Sponsor

Inspire Medical Systems, Inc.

Last update posted

Mar 27, 2026

Last verified

Aug, 2025

Keywords

  • Obstructive Sleep Apnea
  • OSA
  • Inspire
  • AHI

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Inspire Medical Systems, Inc. on 2026-03-27.